MDxHealth SA - 16 Year Stock Price History | MDXH
Historical daily share price chart and data for MDxHealth SA since 2009 adjusted for splits and dividends. The latest closing stock price for MDxHealth SA as of April 24, 2025 is 1.73.
- The all-time high MDxHealth SA stock closing price was 90.00 on October 19, 2009.
- The MDxHealth SA 52-week high stock price is 3.50, which is 102.3% above the current share price.
- The MDxHealth SA 52-week low stock price is 1.35, which is 22% below the current share price.
- The average MDxHealth SA stock price for the last 52 weeks is 2.25.
| MDxHealth SA Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.7477 | 2.3000 | 2.3500 | 1.4100 | 1.7300 | -27.00% |
| 2024 | 2.7276 | 4.1400 | 4.4800 | 1.5700 | 2.3700 | -39.85% |
| 2023 | 3.2442 | 0.0010 | 4.0800 | 0.0010 | 3.9400 | 393900.00% |
| 2022 | 5.5430 | 6.0000 | 7.0000 | 0.0010 | 0.0010 | -99.99% |
| 2021 | 13.2251 | 11.1000 | 17.8000 | 10.4000 | 10.4000 | 2.97% |
| 2020 | 9.1729 | 10.9380 | 11.0000 | 6.4500 | 10.1000 | -8.18% |
| 2019 | 15.5269 | 26.0000 | 26.0000 | 10.0000 | 11.0000 | -43.59% |
| 2018 | 37.2534 | 39.0000 | 50.0000 | 17.5000 | 19.5000 | -54.55% |
| 2017 | 51.8521 | 50.5000 | 61.5000 | 41.5000 | 42.9000 | -10.06% |
| 2016 | 42.1895 | 42.0000 | 51.2000 | 36.9000 | 47.7000 | 9.66% |
| 2015 | 50.3488 | 54.5000 | 60.0000 | 39.0000 | 43.5000 | -23.01% |
| 2014 | 50.7915 | 40.2000 | 67.0000 | 39.4000 | 56.5000 | 40.83% |
| 2013 | 33.6523 | 30.0000 | 40.7000 | 26.6000 | 40.1200 | 30.26% |
| 2012 | 23.0000 | 23.8000 | 30.8000 | 18.0000 | 30.8000 | 24.09% |
| 2011 | 28.7733 | 32.5000 | 32.5000 | 24.8200 | 24.8200 | 29.27% |
| 2010 | 34.3633 | 60.6800 | 60.6800 | 19.0000 | 19.2000 | -70.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.076B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |